Raidium has developed the first-ever radiological foundation model, referred to as the 'GPT' of radiology.
Pierre Manceron · Directeur Général · decision-maker
Paul Herent · Director · decision-maker
Careers mailbox is known
Sep 18
Hiring 1 closed in 14 days
Jul 17
Launched Raidium Launches AI-Native Radiology Platform Across US Cancer Centers · hitconsultant.net
Nov 1, 2024
Won a grant $2.7M · CORDIS
2022
Founded
Premier EEG intra-auriculaireAUTORISÉ par la FDA. Une surveillance cérébrale de niveau médical pour les professionnels aujourd'hui, et une plateforme EEG déployable sur les objets connectés demain.
No named decision-maker yet.
Careers mailbox is known
About us. Our Leadership team is composed of seasoned professionals with a strong expertise in the orphan diseases and gene therapy field.
Jean-Philippe Combal · Président du conseil d’administration, Président de SAS · decision-maker
Careers mailbox is known
Dec 13, 2017
Increased its share capital $90k · BODACC
Jul 1, 2016
Founded per the company register
Glycan excellence against cancer. About us.
No named decision-maker yet.
Careers mailbox is known
Apr 29
Raised a round Seed $11.9M · The Manila Times
2019
Founded
Synendos Therapeutics advances selective endocannabinoid reuptake inhibitors to restore ECS balance, developing new treatments for anxiety, PTSD and mood disorders.
No named decision-maker yet.
Careers mailbox is known
Nov 11, 2020
Raised a round Series A $22.4M · pharmaphorum
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can equip consulting rooms and adapt to a use in clinical routine, in order to make the liquid biopsy of CTC accessible and the essential medical procedure for the diagnosis, follow-up and personalization of care in medical oncology.
Aline Pinet Cerf · Président de SAS · decision-maker
Careers mailbox is known
Oct 14, 2025
Increased its share capital $1.1M · BODACC
Sep 6, 2016
Founded per the company register
Targeting RyR. A novel mechanism to correct calcium channel dysfunction.
No named decision-maker yet.
Careers mailbox is known
2024
Founded
Recept AI, la plateforme d'engagement patient par IA vocale. Elle répond aux appels 24/7, prend les rendez-vous dans votre logiciel et soulage vos équipes. 0 appel manqué, 3h gagnées par jour.
Ariel Modaï · Représentant légal · decision-maker
Careers mailbox is known
Sep 26, 2025
Increased its share capital $540 · BODACC
PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
No named decision-maker yet.
Careers mailbox is known
Jul 11, 2013
Raised a round Series B $4.1M
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody treatments.
No named decision-maker yet.
Careers mailbox is known
Mission. Axithra's groundbreaking optics and photonics technology aims to revolutionize bedside therapeutic drug monitoring with its unparalleled speed, cost-effectiveness, and accuracy.
No named decision-maker yet.
Careers mailbox is known
Sep 7, 2023
Raised a round Venture round $10M
Dapatkan sensasi taruhan paling transparan di ALEXISTOGEL, wujud nyata bandar toto Macau 4D 5D resmi terlengkap se-Asia dengan siaran live draw tercepat tanpa manipulasi.
Thomas Meyer · Executive Officer, Director · decision-maker
Andrea Braun · Executive Officer · decision-maker
Hernan Levett · Executive Officer · decision-maker
Calvin Roberts · Director
No careers mailbox known
Jan 26, 2018
Raised a round Venture round $5.5M · SEC Form D
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company was founded by the previous founders of Emergence Therapeutics.
No named decision-maker yet.
Careers mailbox is known
Oct 16, 2025
Raised a round Series A $113.4M · The Manila Times
Découvrez Sunrise, le test d'apnée du sommeil sans fil le plus précis au monde. Ronflements, réveils nocturnes, insomnie, fatigue : trouvez un traitement adapté avec un test du sommeil complet, certifié pour l'apnée du sommeil et plus simple que jamais.
No named decision-maker yet.
No careers mailbox known
Dec 15, 2021
Raised a round Venture round $7M · led by Kurma Partners · PRNewswire
Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer.
No named decision-maker yet.
Careers mailbox is known
May 2, 2025
Raised a round Seed $50M · led by EQT Life Sciences · Pulse 2.0
Pioneering Protein Degradation for Targeted Therapies. Laigo Bio is at the forefront of a revolutionary era in biotechnology -one that offers new hope for eradicating disease-causing targets through protein degradation.
No named decision-maker yet.
Careers mailbox is known
Argobio SAS is a newly-created START-UP STUDIO dedicated to novel Therapeutics aiming to nurture and launch at least five breakthrough Biotech companies over the next five years.Argobio will source innovative early-stage projects from renowned European academic research institutions.
Thierry Laugel · Directeur de la publication
No careers mailbox known
Jun 17, 2025
Increased its share capital $52.9M · BODACC
La plateforme IA qui automatise les plannings des médecins et soignants dans 70+ établissements de santé français. IA symbolique propriétaire, conçue en France.
No named decision-maker yet.
Careers mailbox is known
Jun 17, 2022
Dissolved BODACC
Setting a New Standard in Precision Oncology. Next-generation copper-based radiopharmaceuticals enable the highest accuracy and accessibility for targeted cancer treatment.
Anthony Rosenberg · Directors · decision-maker
Careers mailbox is known
May 27
Raised a round Series B
Nov 19, 2024
Board appointment NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board · businesswire.com
May 14, 2023
Partnership NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumou… · businesswire.com
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Moved to Recruitee
2019
Founded
